Altered patterns of phosphorylation in cultured mouse lenses during development of buthionine sulfoximine cataracts

Wenjie Li, Harold I. Calvin, Larry David, Kaili Wu, Ashley L. McCormack, Guan Ping Zhu, S. C. Joseph Fu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Buthionine sulfoximine (BSO), a specific inhibitor of glutathione biosynthesis, induces oxidative cataracts following multiple injections into mice at 1 week of age. Cultures of lenses with 35S-methionine have previously demonstrated altered patterns of protein biosynthesis that precede and accompany these cataracts. To obtain parallel information about changes in protein phosphorylation during cataract development, lenses from BSO-treated or control mouse pups were cultured for 3 hr at 37°C with 32Pi, homogenized in phosphate buffer, and resolved by centrifugation into water-soluble (WS) and water-insoluble (WI) fractions. These were characterized by 2D-gel electrophoresis, Coomassie blue staining, phosphorimaging, immunoblotting, and tandem mass spectrometry. Heaviest labelling was in the WI fraction. The labelled 2D-gel spots included: (1) a series of phosphorylated filensins at 95 kDa; (2) a major radioactive spot at 45-50 kDa, slightly anodic to actin and the beaded filament protein, phakinin (CP 49); (3) a phosphorylated betaB1-crystallin, considerably anodic to parent betaB1; (4) an acidic cluster of labelled alphaA-crystallins, phosphorylated in part at serine-148, and (5) a labelled trace alpha crystallin, slightly anodic to alphaB-crystallin. The results confirm previously reported phosphorylations of actin, phakinin, alphaA- and alphaB-crystallin, demonstrate previously unrecognized phosphorylations of filensin and betaB1-crystallin, and provide unequivocal evidence for phosphorylation of alphaA-crystallin at serine-148. The earliest changes in phosphorylation detected after BSO treatment were increased labelling of alphaA- and alphaB-crystallin during cataract stages 1-3, coupled with a general decrease in protein labelling. In stage 5 cataracts, phosphorylated alpha crystallins persisted as the dominant labelled species. However, the major modifications of alphaA-crystallin in advanced BSO cataracts were unlabelled and partially degraded, in contrast to phosphorylated alphaA. It is therefore proposed that phosphorylation of alphaA-crystallin may confer resistance to proteolytic degradation.

Original languageEnglish (US)
Pages (from-to)335-346
Number of pages12
JournalExperimental Eye Research
Volume75
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Buthionine Sulfoximine
Crystallins
Cataract
Lenses
Phosphorylation
alpha-Crystallins
Serine
Water
Proteins
Electrophoresis, Gel, Two-Dimensional
Protein Biosynthesis
Tandem Mass Spectrometry
Actin Cytoskeleton
Centrifugation
Immunoblotting
Methionine
Glutathione
Actins
Buffers
Gels

Keywords

  • 2D-gel electrophoresis
  • Actin
  • Alpha crystallin
  • Beta crystallin
  • Buthionine sulfoximine
  • Cataract
  • Filensin
  • Immunoblot
  • Lens
  • Mouse
  • Phakinin
  • Phosphorimage
  • Phosphorylation
  • Tandem mass spectrometry

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Altered patterns of phosphorylation in cultured mouse lenses during development of buthionine sulfoximine cataracts. / Li, Wenjie; Calvin, Harold I.; David, Larry; Wu, Kaili; McCormack, Ashley L.; Zhu, Guan Ping; Joseph Fu, S. C.

In: Experimental Eye Research, Vol. 75, No. 3, 2002, p. 335-346.

Research output: Contribution to journalArticle

Li, Wenjie ; Calvin, Harold I. ; David, Larry ; Wu, Kaili ; McCormack, Ashley L. ; Zhu, Guan Ping ; Joseph Fu, S. C. / Altered patterns of phosphorylation in cultured mouse lenses during development of buthionine sulfoximine cataracts. In: Experimental Eye Research. 2002 ; Vol. 75, No. 3. pp. 335-346.
@article{e3894ba2385c41649da538235c7a45bf,
title = "Altered patterns of phosphorylation in cultured mouse lenses during development of buthionine sulfoximine cataracts",
abstract = "Buthionine sulfoximine (BSO), a specific inhibitor of glutathione biosynthesis, induces oxidative cataracts following multiple injections into mice at 1 week of age. Cultures of lenses with 35S-methionine have previously demonstrated altered patterns of protein biosynthesis that precede and accompany these cataracts. To obtain parallel information about changes in protein phosphorylation during cataract development, lenses from BSO-treated or control mouse pups were cultured for 3 hr at 37°C with 32Pi, homogenized in phosphate buffer, and resolved by centrifugation into water-soluble (WS) and water-insoluble (WI) fractions. These were characterized by 2D-gel electrophoresis, Coomassie blue staining, phosphorimaging, immunoblotting, and tandem mass spectrometry. Heaviest labelling was in the WI fraction. The labelled 2D-gel spots included: (1) a series of phosphorylated filensins at 95 kDa; (2) a major radioactive spot at 45-50 kDa, slightly anodic to actin and the beaded filament protein, phakinin (CP 49); (3) a phosphorylated betaB1-crystallin, considerably anodic to parent betaB1; (4) an acidic cluster of labelled alphaA-crystallins, phosphorylated in part at serine-148, and (5) a labelled trace alpha crystallin, slightly anodic to alphaB-crystallin. The results confirm previously reported phosphorylations of actin, phakinin, alphaA- and alphaB-crystallin, demonstrate previously unrecognized phosphorylations of filensin and betaB1-crystallin, and provide unequivocal evidence for phosphorylation of alphaA-crystallin at serine-148. The earliest changes in phosphorylation detected after BSO treatment were increased labelling of alphaA- and alphaB-crystallin during cataract stages 1-3, coupled with a general decrease in protein labelling. In stage 5 cataracts, phosphorylated alpha crystallins persisted as the dominant labelled species. However, the major modifications of alphaA-crystallin in advanced BSO cataracts were unlabelled and partially degraded, in contrast to phosphorylated alphaA. It is therefore proposed that phosphorylation of alphaA-crystallin may confer resistance to proteolytic degradation.",
keywords = "2D-gel electrophoresis, Actin, Alpha crystallin, Beta crystallin, Buthionine sulfoximine, Cataract, Filensin, Immunoblot, Lens, Mouse, Phakinin, Phosphorimage, Phosphorylation, Tandem mass spectrometry",
author = "Wenjie Li and Calvin, {Harold I.} and Larry David and Kaili Wu and McCormack, {Ashley L.} and Zhu, {Guan Ping} and {Joseph Fu}, {S. C.}",
year = "2002",
doi = "10.1016/S0014-4835(02)92008-7",
language = "English (US)",
volume = "75",
pages = "335--346",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Altered patterns of phosphorylation in cultured mouse lenses during development of buthionine sulfoximine cataracts

AU - Li, Wenjie

AU - Calvin, Harold I.

AU - David, Larry

AU - Wu, Kaili

AU - McCormack, Ashley L.

AU - Zhu, Guan Ping

AU - Joseph Fu, S. C.

PY - 2002

Y1 - 2002

N2 - Buthionine sulfoximine (BSO), a specific inhibitor of glutathione biosynthesis, induces oxidative cataracts following multiple injections into mice at 1 week of age. Cultures of lenses with 35S-methionine have previously demonstrated altered patterns of protein biosynthesis that precede and accompany these cataracts. To obtain parallel information about changes in protein phosphorylation during cataract development, lenses from BSO-treated or control mouse pups were cultured for 3 hr at 37°C with 32Pi, homogenized in phosphate buffer, and resolved by centrifugation into water-soluble (WS) and water-insoluble (WI) fractions. These were characterized by 2D-gel electrophoresis, Coomassie blue staining, phosphorimaging, immunoblotting, and tandem mass spectrometry. Heaviest labelling was in the WI fraction. The labelled 2D-gel spots included: (1) a series of phosphorylated filensins at 95 kDa; (2) a major radioactive spot at 45-50 kDa, slightly anodic to actin and the beaded filament protein, phakinin (CP 49); (3) a phosphorylated betaB1-crystallin, considerably anodic to parent betaB1; (4) an acidic cluster of labelled alphaA-crystallins, phosphorylated in part at serine-148, and (5) a labelled trace alpha crystallin, slightly anodic to alphaB-crystallin. The results confirm previously reported phosphorylations of actin, phakinin, alphaA- and alphaB-crystallin, demonstrate previously unrecognized phosphorylations of filensin and betaB1-crystallin, and provide unequivocal evidence for phosphorylation of alphaA-crystallin at serine-148. The earliest changes in phosphorylation detected after BSO treatment were increased labelling of alphaA- and alphaB-crystallin during cataract stages 1-3, coupled with a general decrease in protein labelling. In stage 5 cataracts, phosphorylated alpha crystallins persisted as the dominant labelled species. However, the major modifications of alphaA-crystallin in advanced BSO cataracts were unlabelled and partially degraded, in contrast to phosphorylated alphaA. It is therefore proposed that phosphorylation of alphaA-crystallin may confer resistance to proteolytic degradation.

AB - Buthionine sulfoximine (BSO), a specific inhibitor of glutathione biosynthesis, induces oxidative cataracts following multiple injections into mice at 1 week of age. Cultures of lenses with 35S-methionine have previously demonstrated altered patterns of protein biosynthesis that precede and accompany these cataracts. To obtain parallel information about changes in protein phosphorylation during cataract development, lenses from BSO-treated or control mouse pups were cultured for 3 hr at 37°C with 32Pi, homogenized in phosphate buffer, and resolved by centrifugation into water-soluble (WS) and water-insoluble (WI) fractions. These were characterized by 2D-gel electrophoresis, Coomassie blue staining, phosphorimaging, immunoblotting, and tandem mass spectrometry. Heaviest labelling was in the WI fraction. The labelled 2D-gel spots included: (1) a series of phosphorylated filensins at 95 kDa; (2) a major radioactive spot at 45-50 kDa, slightly anodic to actin and the beaded filament protein, phakinin (CP 49); (3) a phosphorylated betaB1-crystallin, considerably anodic to parent betaB1; (4) an acidic cluster of labelled alphaA-crystallins, phosphorylated in part at serine-148, and (5) a labelled trace alpha crystallin, slightly anodic to alphaB-crystallin. The results confirm previously reported phosphorylations of actin, phakinin, alphaA- and alphaB-crystallin, demonstrate previously unrecognized phosphorylations of filensin and betaB1-crystallin, and provide unequivocal evidence for phosphorylation of alphaA-crystallin at serine-148. The earliest changes in phosphorylation detected after BSO treatment were increased labelling of alphaA- and alphaB-crystallin during cataract stages 1-3, coupled with a general decrease in protein labelling. In stage 5 cataracts, phosphorylated alpha crystallins persisted as the dominant labelled species. However, the major modifications of alphaA-crystallin in advanced BSO cataracts were unlabelled and partially degraded, in contrast to phosphorylated alphaA. It is therefore proposed that phosphorylation of alphaA-crystallin may confer resistance to proteolytic degradation.

KW - 2D-gel electrophoresis

KW - Actin

KW - Alpha crystallin

KW - Beta crystallin

KW - Buthionine sulfoximine

KW - Cataract

KW - Filensin

KW - Immunoblot

KW - Lens

KW - Mouse

KW - Phakinin

KW - Phosphorimage

KW - Phosphorylation

KW - Tandem mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=0036402462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036402462&partnerID=8YFLogxK

U2 - 10.1016/S0014-4835(02)92008-7

DO - 10.1016/S0014-4835(02)92008-7

M3 - Article

VL - 75

SP - 335

EP - 346

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 3

ER -